Form 4 holding
EVP, Chief Scientific Officer
Keenova Therapeutics plc
- Security class
- Restricted Stock Units
- Shares / value
- 58,434
- Estimated value
- Report date
- 25 Feb 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount